Biostatistics and Bioinformatics for COVID-19 drug development

61 - PCR-Digital-1

Service description

Statistics applied to drug development allow the analysis of large panels of data according to one or more variables. Bioinformatics refers to the analysis of sequences from the NGS or large sets of data from other experimentations.

This service is designed for Biotech companies developing SARS-CoV-2 new drugs.

Materials to provide

  • Details about the project

    Further details on the project may be requested.

You will be able to exchange directly with the experts after filling in the form below.

Typical deliverables

  • Study following the specifications validated with the Expert

Get started with your COVID-19 related bioinformatics request

Please answer the fields below to be contacted by our team of scientists

section1-3
Back
home